Location: Syosset, NY
CIK: 0001892770 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 12, 2026
Total Value: $189M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CLST | Catalyst Pharmaceuticals, Inc. | 114,000 | $3.583M | 1.9% | $31.43 | — | Common | 14888L101 |
| SPRB | Spruce Biosciences, Inc. | 20,000 | $1.08M | 0.6% | $54.00 | — | Common | 85209E208 |
| — | DuPont de Nemours, Inc. | 3,767 | $511K | 0.3% | $135.64 | — | Common | 36614N201 |
| INSM | Insmed Incorporated | 4,253 | $453K | 0.2% | $106.62 | — | Common | 457669307 |
| LBRX | LB Pharmaceuticals, Inc. | 12,965 | $421K | 0.2% | $32.45 | — | Common | 50180M108 |
| CDNA | CareDx, Inc. | 13,630 | $388K | 0.2% | $28.50 | — | Common | 14167L103 |
| QTTB | Q32 Bio Inc | 30,412 | $387K | 0.2% | $12.74 | — | Common | 746964105 |
| ELVN | Enliven Therapeutics, Inc. | 6,183 | $314K | 0.2% | $50.75 | — | Common | 29337E102 |
| BSX | Boston Scientific Corporation | 6,000 | $256K | 0.1% | $42.68 | — | Common | 101137107 |
| FSK | FS KKR Capital Corp. | 2,875 | $30,187 | 0.0% | $10.50 | — | Common | 302635206 |
| OXY/WS | Occidential Pertro Wts exp. 8/3/27 | 194 | $4,268 | 0.0% | $22.00 | — | Common | 674599162 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 147,282 (+4.7%) | $8.367M (+100.3%) | 4.4% | $12.74 | — | Common | 89422G107 |
| ALKS | Alkermes PLC | 121,759 (+1.5%) | $6.38M (+50.3%) | 3.4% | $30.74 | — | Common | G01767105 |
| CGEM | Cullinan Therapeutics, Inc. | 69,182 (+185.9%) | $1.26M (+266.3%) | 0.7% | $16.03 | — | Common | 230031106 |
| HELP | Cybin Inc | 370,000 (+5.7%) | $2.446M (+45.6%) | 1.3% | $7.34 | — | Common | 23256X407 |
| RARE | Ultragenyx Pharmaceutical Inc. | 38,069 (+15.1%) | $1.271M (+83.5%) | 0.7% | $34.04 | — | Common | 90400D108 |
| MDGL | Madrigal Pharmaaceuticals, Inc. | 3,000 (+50.0%) | $1.611M (+53.9%) | 0.9% | $377.61 | — | Common | 558868105 |
| AGIO | Agios Pharmaceutical, Inc. | 95,058 (+2.1%) | $3.528M (+12.1%) | 1.9% | $29.56 | — | Common | 00847X104 |
| SNDX | Syndax Pharmaceutical, Inc. | 437,245 (+3.6%) | $9.558M (-3.0%) | 5.1% | $14.84 | — | Common | 87164F105 |
| COGT | Cogent Biosciences Inc. | 111,081 (+6.8%) | $4.299M (+7.4%) | 2.3% | $28.95 | — | Common | 19240Q201 |
| BBIO | Bridgebio Pharma, Inc. | 92,850 (+3.2%) | $6.915M (+3.5%) | 3.7% | $40.26 | — | Common | 10806X102 |
| SLDB | Solid Bioscience Inc. | 56,208 (+19.2%) | $562K (+65.4%) | 0.3% | $5.08 | — | Common | 83422E204 |
| PTHS | Pelthos Therapeutics, Inc. | 22,073 (+4.7%) | $624K (+40.9%) | 0.3% | $27.17 | — | Common | 171126204 |
| ARDX | Ardelyx, Inc. | 263,168 (+27.1%) | $1.342M (+8.2%) | 0.7% | $6.65 | — | Common | 039697107 |
| RLMD | Relmada Therapeutics, Inc. | 451,000 (+2.7%) | $3.121M (+2.1%) | 1.6% | $4.09 | — | Common | 75955J402 |
| CNTB | Connect Biopharma Holdings Limited | 444,862 (+14.7%) | $1.059M (+4.2%) | 0.6% | $2.31 | — | Common | G23549101 |
| VSTM | Verastem Inc. | 155,000 (+49.0%) | $592K (+7.4%) | 0.3% | $5.60 | — | Common | 92337C203 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals, Inc. | 120,000 | $2.971M | 1.6% | $14.73 | — | — | 14888U101 |
| — | Arcellx Inc | 19,433 | $2.231M | 1.2% | $82.10 | — | — | 03940c100 |
| CYTK | Cytokinetics, Incorporated | 23,644 | $1.558M | 0.8% | $43.67 | — | — | 23282W605 |
| CNTA | Centessa Pharmaceuticals PLC | 39,000 | $1.549M | 0.8% | $38.21 | — | — | 152309100 |
| ADMA | ADMA Biologics, Inc. | 60,200 | $542K | 0.3% | $16.85 | — | — | 000899104 |
| — | Biohaven Pharmaceutical Holding Co. Ltd | 60,720 | $514K | 0.3% | $8.46 | — | — | G111OE107 |
| — | Evolus, Inc. | 99,338 | $408K | 0.2% | $6.65 | — | — | 30052c107 |
| LENZ | LENZ Therapeutics, Inc. | 33,732 | $309K | 0.2% | $27.20 | — | — | 52635N103 |
| DD | DuPont de Nemours, Inc. | 3,767 | $173K | 0.1% | $29.21 | — | — | 26614N102 |
| JSPR | Jasper Therapeutics, Inc. | 160,789 | $141K | 0.1% | $2.98 | — | — | 471871202 |
| MREO | Mereo BioPharm Group PLC | 300,337 | $99,111 | 0.1% | $3.72 | — | — | 589492107 |
| — | FS KKR Capital Corp. | 2,875 | $29,267 | 0.0% | $10.18 | — | — | 302635107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | 2,000 (-85.3%) | $115K (-86.1%) | 0.1% | $53.03 | — | Common | 110122108 |
| TGTX | TG Therapeutics, Inc. | 66,839 (-25.7%) | $3.672M (+22.8%) | 1.9% | $31.16 | — | Common | 88322Q108 |
| JPM | JPMorgan Chase & Co. | 18,098 (-7.1%) | $5.924M (+3.4%) | 3.1% | $142.30 | — | Common | 46625H100 |
| OXY | Occidental Petroleum Corporation | 469 (-29.3%) | $22,779 (-34.4%) | 0.0% | $36.77 | — | Common | 674599105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GOOG | Alphabet Inc-Cl C | 91,420 | $32.3M | 17.1% | $112.46 | — | Common | 02079K107 |
| XERS | Xeris Biopharma Holdings, Inc. | 1,060,000 | $8.395M | 4.4% | $2.77 | — | Common | 98422E103 |
| APO | Apollo Global Management, Inc. | 225,000 | $26.62M | 14.1% | $64.08 | — | Common | 03769M106 |
| PTGX | Protagonist Therapeutics, Inc | 63,000 | $7.723M | 4.1% | $28.54 | — | Common | 74366E102 |
| IOVA | Iovance Biotherapeutics, Inc. | 1,600,000 | $6.656M | 3.5% | $2.68 | — | Common | 462260100 |
| RZLT | Rezolute, Inc. | 370,000 | $1.924M | 1.0% | $6.57 | — | Common | 76200L309 |
| RCUS | Arcus Biosciences, Inc. | 81,241 | $2.505M | 1.3% | $11.78 | — | Common | 03969F109 |
| XBI | SPDR S&P Biotech ETF | 15,000 | $2.374M | 1.3% | $113.51 | — | Common | 78464A870 |
| — | LPL Financial Holdings Inc. | 16,500 | $4.648M | 2.5% | $300.83 | — | Common | 52012V100 |
| DCGO | DocGo, Inc. | 2,670,850 | $1.378M | 0.7% | $6.66 | — | Common | 256086109 |
| VRDN | Viridian Therapeutics, Inc. | 181,000 | $3.325M | 1.8% | $21.03 | — | Common | 92790C104 |
| CNQ | Canadian Natural Resources Limited | 16,800 | $664K | 0.4% | $27.07 | — | Common | 136385101 |
| KURA | Kura Oncology, Inc. | 52,767 | $579K | 0.3% | $7.51 | — | Common | 50127T109 |
| BIIB | Biogen Inc. | 4,000 | $864K | 0.5% | $153.97 | — | Common | 09062X103 |
| PFE | Pfizer Inc. | 32,337 | $779K | 0.4% | $30.29 | — | Common | 717081103 |
| IBB | iShares Biotechnology ETF | 5,500 | $1.046M | 0.6% | $142.31 | — | Common | 464287556 |
| AB | AllianceBernstein Holding L.P. | 48,000 | $1.691M | 0.9% | $48.83 | — | Common | 01881G106 |
| AAPL | Apple Inc. | 2,494 | $722K | 0.4% | $153.75 | — | Common | 037833100 |
| RHP | Ryman Hospitality Properties, Inc. | 2,400 | $309K | 0.2% | $92.38 | — | Common | 78377T107 |
| IBM | International Business Machines | 2,142 | $602K | 0.3% | $120.73 | — | Common | 459200101 |
| VERA | Vera Therapeutics, Inc. | 26,000 | $1.116M | 0.6% | $26.34 | — | Common | 92337R101 |
| WVE | Wave Life Science Ltd. | 40,000 | $232K | 0.1% | $7.91 | — | Common | Y95308105 |
| AVGO | Broadcom, Inc. | 710 | $268K | 0.1% | $147.45 | — | Common | 11135F101 |
| RAIN | Rain Enhancement Technologies Holdco Inc | 101,686 | $210K | 0.1% | $2.94 | — | Common | 75080J103 |
| JNJ | Johnson & Johnson | 4,922 | $1.25M | 0.7% | $150.82 | — | Common | 478160104 |
| IVVD | Invivyd, Inc. | 100,000 | $87,240 | 0.0% | $0.89 | — | Common | 00534A102 |
| CLOZ | The Panagram BBB-B CLO ETF | 47,807 | $1.263M | 0.7% | $26.36 | — | Common | 81752T528 |
| NVDA | Nvidia Corp | 1,280 | $256K | 0.1% | $92.83 | — | Common | 67066G104 |
| KMB | Kimberly-Clark Corporation | 2,400 | $263K | 0.1% | $115.26 | — | Common | 494368103 |
| URI | United Rental, Inc. | 78 | $88,365 | 0.0% | $284.96 | — | Common | 911363109 |
| PWR | Quanta Services, Inc. | 176 | $127K | 0.1% | $220.68 | — | Common | 74762E102 |
| ATRC | AtriCure, Inc. | 51,400 | $1.438M | 0.8% | $35.05 | — | Common | 04963C209 |
| LEGH | Legacy Housing Corporation | 4,000 | $105K | 0.1% | $22.33 | — | Common | 52472M101 |
| — | Alphabet Inc CL A | 300 | $107K | 0.1% | $1656.67 | — | Common | 02079k305 |
| DOW | Dow Inc. | 1,206 | $32,996 | 0.0% | $45.04 | — | Common | 260557103 |
| OBIO | Orchestra Biomed Holdings, Inc. | 253,651 | $1.095M | 0.6% | $3.12 | — | Common | 68572M106 |
| EBC | Eastern Bankshares Inc | 5,000 | $111K | 0.1% | $14.08 | — | Common | 27627N105 |
| IWP | iShares Russell Mid-Cap Growth | 695 | $102K | 0.1% | $136.94 | — | Common | 464287481 |
| JAAA | Janus Henderson AAA CLO ETF | 93,528 | $4.722M | 2.5% | $50.69 | — | Common | 47103U845 |
| AMZN | Amazon.com Inc. | 300 | $71,502 | 0.0% | $125.13 | — | Common | 023135106 |
| — | United Healthcare Corp. | 57 | $23,691 | 0.0% | $508.77 | — | Common | 91324p102 |
| BRSL | International Game Technology PLC | 2,500 | $26,800 | 0.0% | $14.25 | — | Common | G4863A108 |
| MSFT | Microsoft Corporation | 1,600 | $597K | 0.3% | $307.17 | — | Common | 594918104 |
| CRM | Salesforce, Inc. | 77 | $12,063 | 0.0% | $174.57 | — | Common | 79466L302 |
| CTVA | Corteva, Inc. | 1,206 | $102K | 0.1% | $43.54 | — | Common | 22052L104 |
| KD | Kyndryl Holdings Inc. | 428 | $4,841 | 0.0% | $14.19 | — | Common | 50155Q100 |
| MDLZ | Mondelez International, Inc. | 3,000 | $174K | 0.1% | $63.41 | — | Common | 609207105 |
| — | Blackstone Group LP | 210 | $24,711 | 0.0% | $95.24 | — | Common | 09260d107 |
| TMO | Thermo Fisher Scientific, Inc. | 45 | $22,561 | 0.0% | $544.70 | — | Common | 883556102 |
| GEHC | GE HealthCare Technologies Inc | 50 | $3,200 | 0.0% | $69.79 | — | Common | 36266G107 |
| STWD | Starwood Property Trust, Inc. | 400 | $6,552 | 0.0% | $25.00 | — | Common | 85571B105 |
| DHR | Danaher Corporation | 180 | $34,286 | 0.0% | $226.23 | — | Common | 235851102 |
| WAB | Wabtec Corporation | 6 | $1,618 | 0.0% | $89.57 | — | Common | 929740108 |